Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Graft vs Host Disease 1Burkitt Lymphoma 1Blast Crisis 1Anemia, Aplastic 1Anemia 1

Interventions

fludarabine phosphate 14Cyclophosphamide 14Whole-Body Irradiation 12Tacrolimus 10Melphalan 10Mycophenolic Acid 9Busulfan 8fludarabine 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 4Antilymphocyte Serum 4Alemtuzumab 4thymoglobulin 3Thiotepa 2Stem Cell Transplantation 2Sirolimus 2Etoposide 2Cyclosporine 2AP 1903 reagent 2visilizumab 1sargramostim 1methanesulfonic acid 1merphos 1Transplantation 1Teriparatide 1Rituximab 1Radiotherapy 1Radiation 1Parathyroid Hormone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anemia, Aplastic × Immunosuppression Therapy × Clear all
NCT00987480 2018-07-10

Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
45 enrolled 12 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡